Navigation Links
Gene Therapy - Technologies, Markets and Companies
Date:11/30/2011

rders 335

8. Gene therapy of viral infections 338

Introduction 338

Acquired Immunodeficiency Syndrome (AIDS) 338

Current management of AIDS 338

Gene therapy strategies in HIV/AIDS 339

HIV/AIDS vaccines 339

Insertion of protective genes into target cells. 340

Cell/gene therapies for HIV/AIDS 341

Transplantation of genetically modified T-cells 341

Transplantation of genetically modified hematopoietic cells 341

Anti-HIV ribozyme delivered in hematopoietic progenitor cells 342

Inhibition of HIV-1 replication by lentiviral vectors 342

VRX496 342

Intracellular immunization 343

Engineered cellular proteins such as soluble CD4s 343

Intracellular antibodies 343

Anti-rev single chain antibody fragment 343

Use of genes to chemosensitize HIV-1 infected cells 344

Autocrine interferon (INF)-? production by somatic cell gene therapy 344

Antisense approaches to AIDS 344

RNA decoys 344

Antisense oligodeoxynucleotides 344

RNA decoys 345

Ribozymes 345

RNAi applications in HIV/AIDS 346

siRNA-directed inhibition of HIV-1 infection 346

Role of the nef gene during HIV-1 infection and RNAi 346

Bispecific siRNA constructs 347

Targeting CXCR4 with siRNAs 347

Targeting CCR5 with siRNAs 347

Companies involved in developing gene therapy for HIV/AIDS 348

Conclusions regarding gene therapy of HIV/AIDS 349

Genetic vaccines for other viral infections 349

Cytomegalic virus infections 349

Viral hepatitis 350

Vaccine for hepatitis B virus 350

Vaccine for hepatitis C virus 351

Vaccine for herpes simplex virus 351

DNA vaccine against rabies 351

DNA vaccine for Ebola 352

Vaccines for avian influenza 352

Future prospects of DNA vaccines for avian influenza 353

Human trial of a DNA vaccine for avian influenza 3
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Data From REMEDEE Trial Featuring OrbusNeichs Combo™ Dual Therapy Stent to be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011
2. Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis
3. Progenitor Cell Therapy, a Wholly-Owned Subsidiary of NeoStem, Inc., Announces Additions to Management
4. NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
5. New Findings Reported by TJ Gan and Authors from Duke Anesthesiology Demonstrate Efficacy of Cheetah Medicals NICOM® Bioreactance® Technology to Guide Goal Directed Intraoperative Therapy
6. Antigen Express to Present at Second Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference at the New York Academy of Medicine
7. KGI Professor Awarded Patent for Stem-Cell Therapy Aiding Heart-attack Patients
8. NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011
9. EGEN, Inc. Collaborates With Nanotechnology Characterization Laboratory on Brain Cancer Therapy
10. SanBio Announces Site Opening of Phase 1/2a Clinical Trial of Novel Cell Therapy in Stable Stroke Patients at University of Pittsburgh Medical Center
11. Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... (PRWEB) October 30, 2014 Spartan Bioscience ... Spartan RX CYP2C19 System . It detects CYP2C19 genetic ... cheek swab. , The Spartan RX CYP2C19 System is ... has been approved in Canada. Due to the system’s ... may be used by healthcare professionals such as doctors, ...
(Date:10/30/2014)... Avure Technologies celebrates a year of success and the one-year ... of high volume High Pressure Processing (HPP) systems. , “We’re ... PackExpo this year, which is where we first announced the ... CEO at Avure. “Sales of the new Avure machine are ... challenges of market demand for higher throughput. We sold our ...
(Date:10/30/2014)... Calif. , Oct. 30, 2014 Isis Pharmaceuticals, ... therapeutics, today announced that management will present a company overview ... at 8:30 a.m. ET in Boston, MA. ... be available on the "Investors & Media" section of the ... on the Isis website within 48 hours and will be ...
(Date:10/30/2014)... , Oct. 30, 2014  Regado Biosciences, Inc. ... will hold a conference call and live audio webcast ... to discuss its third quarter 2014 financial results. ... call by dialing (888) 347-1165 for domestic callers or ... be webcast live under the investor relations section of ...
Breaking Biology Technology:Health Canada approves first near-patient DNA test for personalized medicine 2Health Canada approves first near-patient DNA test for personalized medicine 3In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2Regado Biosciences to Provide Third Quarter 2014 Financial Results 2
... HOBOKEN, N.J. , Aug. 2 Octapharma USA ... Grants Program is the Rush Hemophilia & Thrombophilia Center at ... pre-clinical research focused on human protein therapies in hematology, immune therapy, intensive care ... ...
... CLEVELAND , Aug. 2 DATATRAK ... focused on global eClinical solutions for the clinical trials ... selected DATATRAK,s eClinical™ platform for a cardiovascular clinical study ... . Reaping the benefits of a unified platform, DAIICHI ...
... enough. Now imagine 15,000 of them. A Northwestern ... 15,000 identical skylines with tiny beams of light using ... Details of the new method, which could do for ... and information transfer, will be published Aug. 1 by ...
Cached Biology Technology:Octapharma Grants Program Awards First Research Grant to Rush University Medical Center 2Octapharma Grants Program Awards First Research Grant to Rush University Medical Center 3Octapharma Grants Program Awards First Research Grant to Rush University Medical Center 4Octapharma Grants Program Awards First Research Grant to Rush University Medical Center 5Octapharma Grants Program Awards First Research Grant to Rush University Medical Center 6DAIICHI SANKYO EUROPE GmbH Selects DATATRAK eClinical™ for Pan-European Systolic Hypertension Study 2DAIICHI SANKYO EUROPE GmbH Selects DATATRAK eClinical™ for Pan-European Systolic Hypertension Study 3DAIICHI SANKYO EUROPE GmbH Selects DATATRAK eClinical™ for Pan-European Systolic Hypertension Study 415,000 beams of light 215,000 beams of light 3
(Date:10/29/2014)... household and industrial products are in the environment – ... of them, scientists have yet to determine whether they ... toward doing that by estimating which substances people are ... in the ACS journal Environmental Science & Technology ... the risks to human health of any given substance ...
(Date:10/29/2014)... Mich. – As bodies decompose, their types and ... clues they provide could mean the difference between ... Michigan State University is using a more than ... Detroit death-scene investigators examine these changing populations. The ... geographical location of death, gender, race, socioeconomic relations ...
(Date:10/29/2014)... new research potential of the Barcode of Life ... the Biodiversity Data Journal (BDJ) ... and imported these into a human-readable text developed in ... Data were used to study the species distributions of ... subfamily. , BOLD is originally designed to support the ...
Breaking Biology News(10 mins):MSU partners with Detroit to investigate death scenes 2Go straight and publish: From Barcode of Life Data Systems to scholarly publishing systems 2
... a type of contaminant in the atmosphere, considered very ... and visibility. Chemist Ms Ainhoa Inza studied the presence ... the Basque Country (CAV-EAE); concretely, the type known as ... micras in diameter. Amongst other things, the researcher compared ...
... Rochester Institute of Technology has been awarded a ... Standards and Technology to assist in construction of ... university,s Golisano Institute for Sustainability. The building will ... transfer, education and outreach and provide a state-of-the-art ...
... University of Wellington, New Zealand, crouched low to the ground and ... plant cushion, then sat back waiting to see if something would ... have thought so, but Pufal was trying to find potential plant ... Although the ability to move is typically thought to ...
Cached Biology News:Thesis studies atmospheric PM contaminant in the Basque Autonomous Community 2RIT receives federal grant to construct new sustainability research facility 2RIT receives federal grant to construct new sustainability research facility 3RIT receives federal grant to construct new sustainability research facility 4Plants that move: How a New Zealand species disperses seeds in a high alpine, wet environment 2Plants that move: How a New Zealand species disperses seeds in a high alpine, wet environment 3
RABBIT ANTI AMPHOTERIN...
Amino Acid Analysis is performed using ion-exchange separation of the amino acids from acid hydrolysates, followed by ninhydrin detection. Typical quantities required are 0.1 to 0.5 mg, depending on...
... by R. Edwards (1996) • ... types of immunoassays, including RIA, ... and on the photoluminescent and ... information is also given on ...
... contains the basic components required for the ... and recombinant Feline IL-10 in cell culture ... materials to run ELISAs on approximately fifteen ... are met: The assay is run ...
Biology Products: